Sun Pharma Advanced Research Company Limited (NSE: SPARC)

NSE: SPARC Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 27, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	65,385	119,521	58,203	80,734	37,250	25,274
Market Cap Growth	-7.36%	105.35%	-27.91%	116.74%	47.38%	-49.52%
Enterprise Value	66,336	116,002	60,088	81,455	38,052	24,802
Last Close Price	201.48	368.30	179.35	296.95	142.15	96.45
Forward PE	-	91.22	91.22	91.22	91.22	91.22
PS Ratio	108.83	158.21	24.38	58.82	14.73	32.90
PB Ratio	-90.56	95.04	11.35	258.55	-22.14	-135.61
P/TBV Ratio	-	143.93	11.94	995.49	-	-
EV/Sales Ratio	110.40	153.55	25.16	59.35	15.04	32.29
EV/FCF Ratio	-14.31	-	-	-	-	-
Debt / Equity Ratio	-1.31	0.49	0.03	2.54	-1.40	-3.67
Asset Turnover	0.12	0.11	0.43	0.54	1.01	0.23
Inventory Turnover	-	28.64	26.43	25.15	20.05	14.00
Quick Ratio	0.07	0.81	2.47	0.25	0.14	0.11
Current Ratio	0.32	1.02	2.54	0.42	0.27	0.29
Return on Equity (ROE)	-321.41%	-121.28%	-81.83%	-	-	-225.08%
Return on Assets (ROA)	-52.41%	-38.26%	-25.18%	-48.08%	-36.26%	-58.67%
Return on Capital (ROIC)	-140.09%	-71.94%	-43.76%	-137.25%	-154.56%	-113.27%
Earnings Yield	-6.25%	-3.24%	-3.82%	-2.52%	-4.06%	-12.36%
FCF Yield	-7.09%	-3.81%	-1.45%	-2.98%	-4.24%	-10.48%
Buyback Yield / Dilution	-4.38%	-13.99%	-8.19%	-0.42%	-	-2.52%
Total Shareholder Return	-4.38%	-13.99%	-8.19%	-0.42%	-	-2.52%

Source: S&P Capital IQ. Standard template. Financial Sources.